Alan Wimmer is a Cardiology physician affiliated with Saint Luke's Hospital. OpenAlex indexes 76 publications with 2,669 citations (h-index 17); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4330 Wornall Rd
Suite 2000
Kansas City, MO 641115939
Telephone
816-931-1883Registry record last updated 16 Nov 2017.
Clinical trials
- NAVISTAR® THERMOCOOL® SF Catheter: Observational Study
Sponsor: Biosense Webster, Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20252 payments
- BIOTRONIK INC.Program year20251 payment
- Biosense Webster, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
71.7%Beta blocker20.2%Metoprolol Succinate52%Carvedilol25%Metoprolol Tartrate11%Sotalol11%Part D≥92 patientsAntiarrhythmic12.4%Flecainide Acetate55%Dofetilide25%Amiodarone Hcl13%Multaq8%Part D≥61 patients+ 12 more classes in this area
Blood & clotting
24.5%Factor Xa inhibitor19.9%Eliquis87%Xarelto13%Part D≥121 patientsVitamin K antagonist2.9%Warfarin Sodium100%Part D≥20 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.7%Potassium supplement1.7%Potassium Chloride100%Part D≥14 patientsProton pump inhibitor1.1%Pantoprazole Sodium100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- An Analysis of Telehealth in the Outpatient Management of Atrial Fibrillation During the COVID-19 Pandemic
The American Journal of Cardiology
2023 - Antibacterial envelope use to prevent cardiac implantable device infection: outcomes from the national readmission database
Journal of Interventional Cardiac Electrophysiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pluard, MD
Saint Luke's Hospital
Adnan Chhatriwalla, MD
Saint Luke's Hospital
Sreenivasa Jonnalagadda, MD
Saint Luke's Hospital
John Yeast, MD
Saint Luke's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”